Radium

thyroid peroxidase ; Homo sapiens







23 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35007700 Risk of thrombosis with thrombopoietin receptor agonists for ITP patients: A systematic review and meta-analysis. 2022 Mar 4
2 35371812 Use of Eltrombopag for the First Trimester Pregnancy Complicated with Refractory Idiopathic Thrombocytopenic Purpura: A Case Report and Literature Review. 2022 Feb 1
3 32281449 Thrombopoietin receptor agonists for the treatment of primary immune thrombocytopenia: a meta-analysis and systematic review. 2021 Feb 17 2
4 32712041 [Adult immune thrombocytopenia and thrombopoietin receptor agonist: Ten years later]. 2021 Jan 1
5 33213987 Hemostatic changes by thrombopoietin-receptor agonists in immune thrombocytopenia patients. 2021 May 1
6 33789275 Tapering and Discontinuation of Thrombopoietin Receptor Agonist Therapy in Patients with Immune Thrombocytopenia: Results from a Modified Delphi Panel. 2021 3
7 34160821 Thrombopoietin Receptor Agonists (TPO-RAs): Drug Class Considerations for Pharmacists. 2021 Jul 1
8 34547980 Treatment patterns in adults with immune thrombocytopenia before, during and after use of thrombopoietin receptor agonists: a longitudinal prescription database study from Germany. 2021 Dec 1
9 34605362 Patient preferences and experiences regarding thrombopoietin-receptor agonists for immune thrombocytopenia in the United Kingdom and Ireland (TRAPeze UK & IE study). 2021 Dec 2
10 30885035 Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists. 2020 1
11 31280643 Increased microvesicle-associated thrombin generation in patients with immune thrombocytopenia after initiation of thrombopoietin receptor agonists. 2020 1
12 32476083 Treatment-free remission after thrombopoietin receptor agonist discontinuation in patients with newly diagnosed immune thrombocytopenia: an observational retrospective analysis in real-world clinical practice. 2020 Aug 1
13 32523658 The role of romiplostim for pediatric patients with immune thrombocytopenia. 2020 1
14 32814348 Use of thrombopoietin receptor agonists for immune thrombocytopenia in pregnancy: results from a multicenter study. 2020 Dec 24 2
15 29215956 Effect of thrombopoietin receptor agonists on markers of coagulation and P-selectin in patients with immune thrombocytopenia. 2019 5
16 29293383 Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment. 2019 1
17 30743272 Platelet Apoptosis and PAI-1 are Involved in the Pro-Coagulant State of Immune Thrombocytopaenia Patients Treated with Thrombopoietin Receptor Agonists. 2019 Apr 2
18 28983953 Alternate use of thrombopoietin receptor agonists in adult primary immune thrombocytopenia patients: A retrospective collaborative survey from Italian hematology centers. 2018 Jan 4
19 27991534 Efficacy and safety of thrombopoietin receptor agonists in patients with primary immune thrombocytopenia: A systematic review and meta-analysis. 2016 Dec 19 2
20 24500066 Effects of thrombopoietin receptor agonists on procoagulant state in patients with immune thrombocytopenia. 2014 Jul 3 1
21 24725224 The temporary use of thrombopoietin-receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study. 2014 Jun 1
22 22185370 Thrombopoietin-receptor agonists in haematological disorders: the Danish experience. 2012 1
23 22740443 How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment. 2012 Aug 2 1